
C-RAD Investor Relations Material
Latest events

Q2 2025
C-RAD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from C-RAD
Access all reports
C-Rad AB, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer. The company offers its products under the C-Rad brand name. The company's endoMulti platform is a digital x-ray equipment with an ionizing radiation emitter and an advanced linac electronics module; and its endoDose platform includes linac platforms that are equipped with C-Rad's advanced dosimetry software. It also provides LINACsystems; and therapeutic linear accelerators and their subsystems. The company markets its products directly to customers through a global network of distributors. The company is based in Uppsala, Sweden.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CRAD
Country
🇸🇪 Sweden